November 18, 2019 / 7:42 AM / a month ago

Consort Medical agrees to 505 mln pound buyout by Sweden's Recipharm

Nov 18 (Reuters) - Consort Medical Plc on Monday said Sweden’s Recipharm AB would buy the London-listed healthcare company for 1,010 pence per share in cash.

Consort said the offer represented a premium of 39.1% to Friday’s close of 726 pence, valuing the company at about 505 million pounds ($646.20 million) on a fully diluted basis. ($1 = 0.7815 pounds) (Reporting by Pushkala Aripaka in Bengaluru; Editing by Subhranshu Sahu)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below